Avience Biomedicals IPO — GMP Today, Price Band, Dates & Listing

Avience Biomedicals SME IPO (NSE: AVIENCE) opened on 18 Jun 2026 and closed on 22 Jun 2026 on NSE SME. Price band Rs 196–208, lot size 600 shares (minimum application Rs 249,600, two lots, the SME minimum application, at the upper band). Listed on 25 Jun 2026 at +99.50% over the issue price on day one.

Avience Biomedicals IPO details

StatusListed
Open date18 Jun 2026
Close date22 Jun 2026
Price bandRs 196–208
Lot size600 shares
Minimum investmentRs 249,600 (two lots, the SME minimum application, at the upper band)
Face valueRs.10
Issue type100 % Book Building
Issue size (NSE summary)Initial Public offering of Fresh Issue of up to 14,53,800 Equity shares (Including Market Maker portion of 82,200 Equity shares and Anchor Allocation of 4,09,800 Equity Shares)
Listing date25 Jun 2026 (listed)
ExchangeNSE SME
Lead managersFintellectual Corporate Advisors Private Limited
RegistrarSkyline Financial Services Private Limited
NSE symbolAVIENCE
ProspectusRed herring prospectus (NSE archive, zip)

Face value, lot, issue type, issue size, lead managers and registrar are as filed on NSE's IPO detail page (AVIENCE). Page data as of 15 Sep 2026.

Subscribed 355.06x on NSE (NSE + BSE combined 354.99x) as of 22 Jun 2026, 18:06 IST (NSE). Category and day-wise breakdown.

Key dates

Issue opens18 Jun 2026
Issue closes22 Jun 2026
Basis of allotment23 Jun 2026 (expected, T+1)
Refunds / demat credit24 Jun 2026 (expected, T+2)
Listing25 Jun 2026 (listed) on NSE SME

Post-close dates follow SEBI's T+3 listing timeline counted in working days from the close; registrar and exchange notices are final.

Avience Biomedicals listing performance

Issue priceRs 208.00
Listed on2026-06-25
Listing day openRs 395.20
Listing day closeRs 414.95
Listing gain (close vs issue)+99.50%
Latest closeRs 349.60
Return since issue+68.08%

Listing-day and latest prices from NSE end-of-day data (symbol AVIENCE). Latest close as of 2026-09-15. Listing-day gain is measured within the listing week and is unaffected by corporate actions; return since issue is price-only, excludes dividends and is not adjusted for splits or bonuses.

What the GMP means for Avience Biomedicals

Grey Market Premium (GMP) is the unofficial premium at which an IPO's shares change hands before listing. A positive GMP signals bullish pre-listing sentiment, but it is unregulated, volatile and routinely diverges from the actual listing price in both directions — treat it as a thermometer, never a forecast. Read our full What is GMP? guide for how the grey market works.

Apply, allotment and listing

FAQs on Avience Biomedicals IPO

What is Avience Biomedicals IPO GMP today?

Avience Biomedicals has listed, so its grey market premium no longer applies. The listing performance table on this page has the actual debut price and gain.

When did the Avience Biomedicals IPO open and close?

Avience Biomedicals's subscription window opened on 18 Jun 2026 and closed on 22 Jun 2026.

What is the Avience Biomedicals IPO price band and lot size?

For Avience Biomedicals, the price band is Rs 196–208 and one lot is 600 shares (minimum application Rs 249,600, two lots, the SME minimum application, at the upper band).

Who is the registrar for the Avience Biomedicals IPO?

The registrar to the Avience Biomedicals IPO is Skyline Financial Services Private Limited (as filed on NSE). Allotment status is checked on the registrar's website once the basis of allotment is finalised — the link is on our Avience Biomedicals allotment status page.

How did Avience Biomedicals perform on listing day?

Avience Biomedicals listed on 25 Jun 2026 and closed its first day at Rs 414.95, +99.50% against the issue price (NSE end-of-day data).

Ready for the next IPO?

Open a free demat account in minutes so you can apply as soon as an issue opens.

Compare brokers for IPO applications